Design, synthesis and biological evaluation of novel (E)-2-benzylidene-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl) hydrazine-1-carboxamide derivatives as α-glucosidase inhibitors

被引:17
|
作者
Zhang, Jin-He [1 ]
Xie, Hong-Xu [1 ]
Li, Yue [1 ]
Wang, Kai-Ming [1 ]
Song, Zhiling [2 ]
Zhu, Kong-Kai [1 ,2 ]
Fang, Lei [1 ]
Zhang, Juan [1 ]
Jiang, Cheng-Shi [1 ]
机构
[1] Univ Jinan, Sch Biol Sci & Technol, Jinan 250022, Peoples R China
[2] Qingdao Univ Sci & Technol, Coll Chem & Mol Engn, Qingdao 266042, Peoples R China
基金
中国国家自然科学基金;
关键词
Hydrazine-carboxamide; alpha-Glucosidase inhibitor; Molecular docking; Cytotoxicity; Hypoglycemic; IN-VITRO EVALUATION; MOLECULAR DOCKING; ISATIN DERIVATIVES; DIABETES-MELLITUS; POTENT;
D O I
10.1016/j.bmcl.2021.128413
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this present study, a series of novel (E)-2-benzylidene-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl) hydrazine-1-carboxamide derivatives against alpha-glucosidase were designed and synthesized, and their biological activities were evaluated in vitro and in vivo. Most of the designed analogues exhibited better inhibitory activity than the marketed acarbose, especially the most potent compound 7 with an IC50 value of 9.26 +/- 1.84 mu M. The direct binding of 7 and 8 with alpha-glucosidase was confirmed by fluorescence quenching experiments, and the kinetic and molecular docking studies revealed that 7 and 8 inhibited alpha-glucosidase in a non-competitive manner. Cytotoxicity bioassay indicated compounds 7 and 8 were non-toxic towards LO2 and HepG2 at 100 mu M. Furthermore, both compounds were demonstrated to have in vivo hypoglycemic activity by reducing the blood glucose levels in sucrose-treated rats.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] LITHIATION OF N,N-DIETHYL-4,5,6,7-TETRAHYDROBENZO[B]THIO[B]THIOPHENE-2-CARBOXAMIDE AND SYNTHESIS OF A NEW [1]BENXOTHIENO[2,3-C]PYRANONE
    MUKHERJEE, S
    DE, A
    JOURNAL OF CHEMICAL RESEARCH-S, 1994, (06): : 238 - 239
  • [32] Synthesis and cytotoxicity evaluation of thiazole derivatives obtained from 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile
    Mohareb, Rafat M.
    Abdallah, Amira E. M.
    Ahmed, Ebtsam A.
    ACTA PHARMACEUTICA, 2017, 67 (04) : 495 - 510
  • [33] Synthesis, cytotoxicity and toxicity of thieno[2,3-d]pyrimidine derivatives derived from 2-amino-3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophene
    Abdelaziz, Mahmoud A.
    El-Sehrawi, Hend M.
    Mohareb, Rafat M.
    MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (11) : 3932 - 3948
  • [34] Synthesis and Biological Evaluation of 2-(4,5,6,7-Tetrahydrobenzo[c]Isoxazol-3-yl)-4H-Chromen-4-Ones
    Dengale, Sujata G.
    Akolkar, Hemantkumar N.
    Darekar, Nirmala R.
    Shaikh, Mubarak H.
    Deshmukh, Keshav K.
    Mhaske, Sadhana D.
    Karale, Bhausaheb K.
    Raut, Dipak N.
    Khedkar, Vijay M.
    POLYCYCLIC AROMATIC COMPOUNDS, 2022, 42 (09) : 6337 - 6351
  • [35] Synthesis, cytotoxicity and toxicity of thieno[2,3-d]pyrimidine derivatives derived from 2-amino-3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophene
    Mahmoud A. Abdelaziz
    Hend M. El-Sehrawi
    Rafat M. Mohareb
    Medicinal Chemistry Research, 2015, 24 : 3932 - 3948
  • [36] E/Z Isomerization of Ethyl 2-Amino-1-(3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-4-oxo-5-(2-oxo-2-phenylethylidene)-4,5-dihydro-1H-pyrrole-3-carboxylate
    Shipilovskikh, Sergei A.
    Gorbunova, Irina A.
    Rubtsov, Aleksandr E.
    MODERN SYNTHETIC METHODOLOGIES FOR CREATING DRUGS AND FUNCTIONAL MATERIALS (MOSM2019), 2020, 2280
  • [37] Synthesis and biological characterization of [3H] (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)(4-chlorophenyl)-methanone, the first radiolabelled adenosine A1 allosteric enhancer
    Baraldi, PG
    Pavani, MG
    Leung, E
    Moorman, AR
    Varani, K
    Vincenzi, F
    Borea, PA
    Romagnoli, R
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (05) : 1402 - 1404
  • [38] Design, synthesis, and evaluation of 4,5,6,7-tetrahydrobenzo[d]thiazole-based novel dual kinase inhibitors of CK2 and GSK3β
    Pardhi, Triveni R.
    Patel, Manishkumar S.
    Sudarsanam, V.
    Vasu, Kamala K.
    MEDCHEMCOMM, 2018, 9 (09) : 1472 - 1490
  • [39] N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3
    Angell, Richard M.
    Atkinson, Francis L.
    Brown, Murray J.
    Chuang, Tsu Tshen
    Christopher, John A.
    Cichy-Knight, Maria
    Dunn, Allison K.
    Hightower, Kendra E.
    Malkakorpi, Susanna
    Musgrave, James R.
    Neu, Margarete
    Rowland, Paul
    Shea, Robyn L.
    Smith, Jeffery L.
    Somers, Donald O.
    Thomas, Sonia A.
    Thompson, Gladstone
    Wang, Ruolan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) : 1296 - 1301
  • [40] Synthesis and biological evaluation of novel active arylidene derivatives of 5,6-dihydro-4H-cyclopenta[b]- and 4,5,6,7-tetrahydrobenzo[b]-thiophene-2-carboxylic acid
    Kathiravan, P. R.
    Venugopal, M.
    Muthukumaran, S.
    RESEARCH ON CHEMICAL INTERMEDIATES, 2017, 43 (04) : 2315 - 2331